Karen Krasney, J.D., serves as the Executive Vice President & General Counsel at Capricor Therapeutics Inc., a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment of rare diseases. With an impressive legal background, Karen brings a wealth of experience and expertise to her role, guiding the company through the complex regulatory landscape of the biotechnology industry. Prior to joining Capricor Therapeutics, Karen held several high-profile positions in the legal field. She began her career as an associate at a prestigious law firm, where she honed her skills in corporate law and intellectual property. Karen's dedication and talent quickly propelled her to the position of partner at another renowned law firm, where she advised numerous biotechnology and pharmaceutical companies on a wide range of legal matters, including mergers and acquisitions, licensing agreements, and regulatory compliance. Her deep understanding of the industry and her ability to navigate complex legal challenges have been instrumental in her success. As Executive Vice President & General Counsel at Capricor Therapeutics, Karen plays a crucial role in the company's growth and development. She is responsible for overseeing all legal matters, including intellectual property protection, corporate governance, and regulatory affairs. Karen's strategic vision and legal acumen have been vital in securing partnerships and collaborations that have propelled the company forward. Her leadership and dedication to advancing Capricor's mission of bringing life-changing therapies to patients with rare diseases have earned her the respect and admiration of her colleagues and the industry at large.